Primary hyperaldosteronism epidemiology and demographics
Overview
Epidemiology and Demographics
Prevalence
- Worldwide, the prevalence of Conn's syndrome (Primary hyperaldosteronism-PA) ranges from a low of 10,000 per 100,000 persons with hypertension to a high of 35,000 per 100,000 persons with hypertenion when aldosterone/renin ratio is used as a screening tool.[1]
- In patients with resistant hypertension, the prevalence of Conn's syndrome (Primary hyperaldosteronism-PA) is reported to be even higher, ranging from a low of 17,000 per 100,000 patients to a high of 23,000 per 100,000 patients.[2]
Incidence
Case-Fatality rate
Age
Gender
Race
- There is no racial predilection for Conn's syndrome (Primary hyperaldosteronism-PA).[3]
- Blacks have been found to have lower plasma renin activity than other populations.[4]
Geographic Distribution
References
- ↑ Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F (2006). "A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients". J. Am. Coll. Cardiol. 48 (11): 2293–300. doi:10.1016/j.jacc.2006.07.059. PMID 17161262.
- ↑ Stowasser M, Taylor PJ, Pimenta E, Ahmed AH, Gordon RD (2010). "Laboratory investigation of primary aldosteronism". Clin Biochem Rev. 31 (2): 39–56. PMC 2874431. PMID 20498828.
- ↑ Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P (2002). "Hyperaldosteronism among black and white subjects with resistant hypertension". Hypertension. 40 (6): 892–6. PMID 12468575.
- ↑ Lee MR, Critchley JA, Gordon CJ, Makarananda K, Sriwatanakul K, Balali-Mood M, Boye GL (1990). "Ethnic differences in the renal sodium dopamine relationship. A possible explanation for regional variations in the prevalence of hypertension?". Am. J. Hypertens. 3 (6 Pt 2): 100S–103S. PMID 2383374.